To investigate the mechanism of EGCG-NPs in the treatment of AD, the expression levels of inflammatory cytokines Th1 (IFN-γ and TNF-α), Th2 (IL-4 and IL-6), and Th17 (IL-17A) were detected (Figure 5). The gene discussed is IL4; the disease is Alzheimer disease.